Table 1.
Types of CBD product use and bivariate comparisons of current (past-month) product use endorsement across CBD-only and CBD+Marijuana co-use groups
| Lifetime CBD use (n=1,060) | Past-year CBD use (n=714) | Past month CBD use | ||||
|---|---|---|---|---|---|---|
| Past month CBD use (all) (n=318) 1 | Past month CBD-only use (n=68) | Past month CBD+Marijuana co-use (n=249) | Unadjusted group difference 2 | |||
| On the days that you use or have used CBD products (i.e., products that contain CBD but DO NOT contain THC), what type(s) of CBD products do/did you typically use. Please check all that apply | p | |||||
| Topical products (e.g., lotions, salves, or creams for external use on the skin) | 39.3% | 44.3% | 52.5% | 52.9% | 52.2% | 0.92 |
| Vaping products (e.g., e-cigarettes or personal vaporizer systems to vape CBD oil or e-liquid) | 29.0% | 30.4% | 35.2% | 20.6% | 39.4% | 0.004 |
| Capsules or pills | 6.0% | 7.8% | 9.1% | 11.8% | 8.4% | 0.40 |
| Edibles (e.g., brownies, gummies, or other candy) | 35.8% | 36.4% | 38.1% | 41.2% | 37.4% | 0.57 |
| Solid concentrates (e.g., dabs, wax, or crystals) | 5.1% | 6.2% | 6.3% | 0.0% | 8.0% | 0.02 |
| Mixed in non-alcoholic beverages (e.g., water, teas, coffee drinks, smoothies, sodas, or other drinks) | 8.6% | 10.2% | 9.8% | 14.7% | 8.4% | 0.12 |
| Mixed in alcoholic beverages (e.g., CBD cocktails) | 2.6% | 3.1% | 3.1% | 1.5% | 3.6% | 0.37 |
| Oils or tinctures (i.e., for oral/sublingual use) | 21.0% | 26.6% | 33.7% | 29.4% | 34.9% | 0.39 |
| Combustible products (e.g., CBD cigarettes) | 4.3% | 5.2% | 6.9% | 2.9% | 8.0% | 0.14 |
Note. Values are percentages of individuals endorsing each response option.
Past-month frequency of CBD use averaged 2.6 (SD = 5.8) days in the past month; 9% of individuals reported using CBD products daily or near-daily (i.e., on 20+ days).Based on bivariate t- and chi-square tests, the CBD+Marijuana co-use and CBD-only groups did not statistically differ with respect to number of CBD use days in the past month (t (df=315)= −1.3, p = .19) or percentage of individuals endorsing daily/near-daily CBD use (X2 (df=1)= 0.94, p = .33).
Group differences in rates of endorsing each type of product across CBD-only and CBD+Marijuana co-use groups were assessed using bivariate chi square tests.